Papers

1

Total Citations

8

H-Index

1

About

Kwang-Lae Hoe is a prominent researcher in functional genomics and chemical biology, with a focus on elucidating drug mechanisms using model organisms. His major contributions center on the development and application of genome-wide screening techniques, particularly in fission yeast, to identify molecular targets of bioactive compounds. His notable work includes a 2008 study on hydrazinocurcumin (HC), a synthetic curcumin derivative with anti-angiogenic properties, where he employed a genome-wide drug-induced haploinsufficient screening approach to uncover HC's cellular targets. This work, cited 8 times, exemplifies his innovative strategy for connecting drug action to genetic pathways, advancing the understanding of how natural product derivatives exert their effects. Hoe's research has significant implications for drug discovery and development, providing a platform for identifying improved pharmacological compounds. His achievements highlight his expertise in integrating genomics, cell biology, and pharmacology to decode complex drug mechanisms, making him a key figure in the field of chemical genetics and target identification.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Genome-wide drug-induced haploinsufficient screening of fission yeast for identification of hydrazinocurcumin targets.
8 citations · 2008
📈 Most Prolific Year: 2008 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Korea Research Institute of Bioscience and Biotechnology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago